p> [10]   Keavney, B., McKenzie, C., Parish, S., Palmer, A., Clark, S., et al. (2000) Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. Lancet, 355, 434-442. http://dx.doi.org/10.1016/S0140-6736(00)82009-7

[11]   Sayed-Tabatabaei, F.A., Houwing-Duistermaat, J.J., Van Duijn, C.M. and Witteman, J.C. (2003) Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke, 34, 1634-1639.

[12]   Bonnici, F., Keavney, B., Collins, R. and Danesh, J. (2002) Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: Meta-analysis of 16 studies. British Medical Journal, 325, 517-520.

[13]   National Institute of Child Health and Development (2001) Conference summary: Amniotic fluid biology-basic and clinical aspects. The Journal of Maternal-Fetal Medicine, 10, 2-19. http://dx.doi.org/10.1080/jmf.

[14]   Altman, D.J. and Chitty, L.S. (1993) Design and analysis of studies to derive fetal charts of fetal size. Ultrasound in Obstetrics & Gynecology, 3, 378-384.

[15]   Chudleigh, T. and Thilaganathan, B. (2004) Routine second trimester screening-assessing of gestational age. In: Chudleigh, T. and Thilaganathan, B., Eds., Patricia Obstetric Ultra-Sound: How Why, and When? 3rd Edition, Elsevier Churchil Living Stone, 95-112.

[16]   Figen, G., Elif, B., Hulya, Y., Turgay, S. and Ahmet, D. (2004) The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clinica Chimica Acta, 341, 127-131.

[17]   Roberts, J.M. and Lain, K.Y. (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta, 23, 359-372.

[18]   Shim, S.S., Shim, J.Y., Lim, J.H., Park, J.S., Jun, J.K., Bai, K.B., Yoon, B.H. and Syn, H.C. (2003) Molecular biological approach to find out the etiology of hypertensive disorder in pregnancy: Analysis of the polymorphism in the promoter of human angiotensinogen gene in Korean population. Korean Journal of Obstetrics & Gynecology, 46, 1486-1492.

[19]   Morise, T., Takeuchi, Y. and Takeda, R. (1995) Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. Journal of Internal Medicine, 237, 175-180.

[20]   Langer, B., Grima, M., Coquard, C., Bader, A.M., Schlaeder, G. and Imbs, J.L. (1998) Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstetrics & Gynecology, 91, 196-202.

[21]   Rasmussen, A.B., Pedersen, E.B., Romer, F.K., Johannesen, P., Kristensen, S., Lauritsen, J.G. and Wohlert, M. (1983) The influence of normotensive pregnancy and pre-eclampsia on angiotensin-converting enzyme. Acta Obstetricia et Gynecologica Scandinavica, 62, 341-344.

[22]   Roh, C.R., Kim, D.K., Yoon, B.K., Yang, S.H., Chung, J.H., Bae, D.S. and Lee, J.H. (1997) A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders. Korean Journal of Obstetrics & Gynecology, 40, 1189-1199.

[23]   Roberts, C.B., Rom, L., Moodley, J. and Pegoraro, R.J. (2007) Hypertension-related gene polymorphisms in preeclampsia, eclampsia and gestational hypertension in Black South African women. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 131, 115-126.

[24]   Knyrim, E., Muetze, S., Eggermann, T., Rudnik-Schoeneborn, S., Lindt, R., Ortlepp, J.R., Rath, W. and Zerres K. (2008) Genetic analysis of the Angiotensinogen gene in pre-eclampsi. Gynecologic and Obstetric Investigation, 66, 203-208. http://dx.doi.org/10.1159/000146084

[25]   Choi, H., Kang, J.Y., Yoon, H.S., et al. (2004) Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. Journal of Hypertension, 22, 945-948.

[26]   Kobashi, G. (2003) Gene polymorphisms and preeclampsia in Japanese; Analysis for gene-environment interaction. Acta Obstetrica et Gynaecologica Japonica, 55, 817-829 .

[27]   Laskowska, M., Laskowska, K. and Oleszczuk, J. (2002) Angiotensin-converting enzyme activity in pre-eclampsia. International Journal of Gynecology and Obstetrics, 77, 33-34. http://dx.doi.org/10.1016/S0020-7292(01)00580-X

[28]   Jacob, H.J., Lindpaintner, K., Lincoln, S.E., Kusumi, K., Bunker, R.K., Mao, Y.P., Ganten, D., Dzau, V.J. and Lander, E.S. (1991) Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell, 67, 213-224.

[29]   Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y.V., Lifton, R.P., Williams, C.S., Charru, A., Hunt, S.C., Hopkins, P.N., Williams, R.R., Lalouel, J.M. and Corvol, P. (1992) Molecular basis of human hypertension: Role of angiotensinogen. Cell, 71, 169-180.

[30]   August, P. and Sealey, J.E. (1990) The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function. Hypertension; Pathophysiology, Diagnosis, and Management, 1761-1778.

[31]   Yu, C.K., Casas, J.P., Savvidou, M.D., Sahemey, M.K., Nicolaides, K.H., et al. (2006) Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a metaanalysis. BMC Pregnancy Childbirth, 6, 7.

[32]   Lin, J. and August, P. (2005) Genetic thrombophilias and preeclampsia: A meta-analysis. Obstetrics & Gynecology, 105, 182-192.

[33]   Rumbold, A.R., Crowther, C.A., Haslam, R.R., Dekker, G.A. and Robinson, J.S., ACTS Study Group (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. New England Journal of Medicine, 354, 1796-1806.

[34]   Hingorani, A.D., Shah, T. and Casas, J.P. (2006) Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. European Heart Journal, 27, 1261-1263.